di-[1]anthryl-amine

• 分子结构分类: 有机化合物 - 苯类化合物 - 蒽
• 英文名称: di-[1]anthryl-amine
• 英文别名: Di-α-anthrylamin；Di-[1]anthryl-amin；α.α-Dianthrylamin；Dianthracenyl-amin；N-anthracen-1-ylanthracen-1-amine
• 化学式: C₂₈H₁₉N
• 分子量: 369.466
• InChiKey: AOYQRESSGNFWTD-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  8.5
• 重原子数：
  29
• 可旋转键数：
  2
• 环数：
  6.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  12
• 氢给体数：
  1
• 氢受体数：
  1

反应信息

• 作为产物：
  描述：

  1-氨基蒽 在 溶剂黄146 作用下， 生成 di-[1]anthryl-amine
  参考文献：
  名称：

  Dienel, Chemische Berichte, 1905, vol. 38, p. 2863

  摘要：

  DOI：

文献信息

• Indole and indazole derivatives, for the treatment and prophylaxis of cerebral disorders, their preparation and their use
  申请人：SANKYO COMPANY LIMITED

  公开号：EP0562832A1

  公开（公告）日：1993-09-29

  Compounds of formula (I) : [in which R¹ and R² are each hydrogen or various organic groups, p is 0, 1, 2 or 3, U is -CO- or -CH(OR³)- where R³ is hydrogen or a hydroxy-protecting group, V is an optionally unsaturated aliphatic hydrocarbon group and W is a nitrogen-containing group] are useful in the treatment and prophylaxis of dementia especially of the Alzheimer's type.

  化合物的化学式（I）：[其中R¹和R²分别为氢或不同的有机基团，p为0、1、2或3，U为-CO-或-CH(OR³)-其中R³为氢或羟基保护基团，V为可选的不饱和脂肪烃基团，W为含氮基团] 在治疗和预防痴呆症，尤其是阿尔茨海默病类型的痴呆症方面是有用的。
• Valuation structure
  作者：Zhaohui Zhu、Zhenghua Pan、Shifu Chen、Wujia Zhu

  DOI：10.2178/jsl/1190150026

  日期：2002.3

  This paper introduces valuation structures associated with preferential models. Based on KLM valuation structures, we present a canonical approach to obtain injective preferential models for any preferential relation satisfying the property INJ, and give uniform proofs of representation theorems for injective preferential relations appeared in the literature. In particular, we show that, in any propositional language (finite or infinite), a preferential inference relation satisfies INJ if and only if it can be represented by a standard preferential model. This conclusion generalizes the result obtained by Freund. In addition, we prove that, when the language is finite, our framework is sufficient to establish a representation theorem for any injective relation.

  本文介绍了与优先模型相关的估值结构。基于KLM估值结构，我们提出了一种规范方法，用于获得任何满足INJ属性的注射式优先模型，并给出了文献中出现的注射式优先关系的统一证明。特别地，我们证明，在任何命题语言（有限或无限），如果优先推理关系满足INJ，那么它可以用标准优先模型来表示。这个结论推广了Freund的结果。此外，我们证明，当语言是有限的时，我们的框架足以为任何注射式关系建立一个表示定理。

• Silacyclopentadiene derivative
  申请人：CHISSO CORPORATION

  公开号：EP0864573A2

  公开（公告）日：1998-09-16

  The present invention provides a silacyclopentadiene derivative represented by the following Formula (1): wherein X1 and Y1 represent independently a halogen atom, an amino group, a hydroxyl group, or an amino group or a hydroxyl group each having a substituent; R1 to R4 represent independently a hydrogen atom, a halogen atom, an alkyl group, an amino group, a silyl group, an aryl group, a cyano group, or the respective groups describe above each having a substituent; out of the groups represented by R1 to R4, those adjacent may be combined with each other to form rings; when R1 and R4 are phenyl groups or when combined are R1 with R2 and R3 with R4 respectively to form benzene rings, X1 and Y1 are not a chlorine atom and a hydroxyl group; and when R1 and R4 are methyl groups, X1 and Y1 are not bromine atoms.

  本发明提供了由下式(1)代表的硅杂环戊二烯衍生物： 其中 X1 和 Y1 独立地代表卤素原子、氨基、羟基或各自具有取代基的氨基或羟基；R1 至 R4 独立地代表氢原子、卤素原子、烷基、氨基、硅烷基、芳基、氰基或上述各自具有取代基的基团；在 R1 至 R4 所代表的基团中，相邻的基团可相互结合形成环；当 R1 和 R4 为苯基或当 R1 与 R2 和 R3 与 R4 分别结合形成苯环时，X1 和 Y1 不是氯原子和羟基；当 R1 和 R4 为甲基时，X1 和 Y1 不是溴原子。
• HOMOGENEOUS ASYMMETRIC HYDROGENATION CATALYST
  申请人：Takasago International Corporation

  公开号：EP2543437A2

  公开（公告）日：2013-01-09

  The present invention provides a catalyst for producing optically active aldehyde or optically active ketone, as an optically active carbonyl compound, by selectively asymmetrically hydrogenating an α, β-unsaturated carbonyl compound, and in particular, a catalyst insoluble in a reaction mixture for obtaining optically active citronellal useful as a flavoring by selectively asymmetrically hydrogenating citral, geranial or neral, and a method for producing the corresponding optically active carbonyl compound. In particular, the present invention provides a method for producing citronellol of identical optical isomers regardless of a mixing ratio of neral and geranial in the asymmetric hydrogenation of citral. In the present invention, the α, β-unsaturated carbonyl compound is asymmetrically hydrogenated using a catalyst including a complex of at least one transition metal selected from transition metals belonging to Group 8 to Group 10 of the Periodic Table, and an optically active cyclic nitrogen-containing compound, and an acid if necessary.

  本发明提供了一种通过选择性不对称氢化α，β-不饱和羰基化合物来生产光学活性醛或光学活性酮，作为光学活性羰基化合物的催化剂，特别是提供了一种不溶于反应混合物的催化剂，用于通过选择性不对称氢化柠檬醛、香叶醇或香叶酯来获得用作香料的光学活性香茅醛，以及生产相应光学活性羰基化合物的方法。特别是，本发明提供了一种在柠檬醛的不对称氢化过程中，无论香叶醇和香叶酯的混合比例如何，都能生产出相同光学异构体的香茅醇的方法。在本发明中，α，β-不饱和羰基化合物使用一种催化剂进行不对称氢化，该催化剂包括至少一种选自属于元素周期表第 8 族至第 10 族的过渡金属的络合物和一种光学活性环状含氮化合物，必要时还包括一种酸。
• v. Braun; Bayer, Justus Liebigs Annalen der Chemie, 1929, vol. 472, p. 104
  作者：v. Braun、Bayer

  DOI：——

  日期：——